Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $355.14 | 10 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| CALLIDITAS THERAPEUTICS US INC. | $121.43 | 1 | $0 (2024) |
| GlaxoSmithKline, LLC. | $39.46 | 2 | $0 (2023) |
| Mallinckrodt LLC | $37.23 | 1 | $0 (2018) |
| Leadiant Biosciences, Inc. | $33.66 | 1 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $26.64 | 1 | $0 (2024) |
| Astellas Pharma US Inc | $25.67 | 1 | $0 (2024) |
| RECORDATI_RARE_DISEASES_INC. | $23.92 | 1 | $0 (2022) |
| Azurity Pharmaceuticals, Inc. | $23.60 | 1 | $0 (2022) |
| Alexion Pharmaceuticals, Inc. | $23.53 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $207.40 | 4 | CALLIDITAS THERAPEUTICS US INC. ($121.43) |
| 2023 | $39.46 | 2 | GlaxoSmithKline, LLC. ($39.46) |
| 2022 | $71.05 | 3 | RECORDATI_RARE_DISEASES_INC. ($23.92) |
| 2018 | $37.23 | 1 | Mallinckrodt LLC ($37.23) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/15/2024 | Astellas Pharma US Inc | Cresemba (Drug) | Food and Beverage | In-kind items and services | $25.67 | General |
| Category: Infectious Diseases | ||||||
| 05/29/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $121.43 | General |
| Category: Nephrology | ||||||
| 04/30/2024 | Takeda Pharmaceuticals U.S.A., Inc. | LIVTENCITY (Drug) | Food and Beverage | In-kind items and services | $26.64 | General |
| Category: IMMUNOLOGY | ||||||
| 02/09/2024 | Leadiant Biosciences, Inc. | CYSTARAN (Drug) | Food and Beverage | In-kind items and services | $33.66 | General |
| Category: CYSTINOSIS | ||||||
| 10/13/2023 | GlaxoSmithKline, LLC. | JESDUVROQ (Drug) | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: NEPHROLOGY | ||||||
| 01/14/2023 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2022 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $23.53 | General |
| Category: Rare Disease | ||||||
| 11/11/2022 | Azurity Pharmaceuticals, Inc. | Qbrelis (Drug) | Food and Beverage | In-kind items and services | $23.60 | General |
| Category: pediatric hypertension | ||||||
| 09/24/2022 | RECORDATI_RARE_DISEASES_INC. | CARBAGLU (Drug), CYSTADROPS, PANHEMATIN | Food and Beverage | In-kind items and services | $23.92 | General |
| Category: METABOLIC AGENT | ||||||
| 03/09/2018 | Mallinckrodt LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $37.23 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
About Dr. Kristianna Singh, MBBS
Dr. Kristianna Singh, MBBS is a Pediatric Nephrology healthcare provider based in Augusta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/20/2016. The National Provider Identifier (NPI) number assigned to this provider is 1043664501.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kristianna Singh, MBBS has received a total of $355.14 in payments from pharmaceutical and medical device companies, with $207.40 received in 2024. These payments were reported across 10 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($355.14).
Practice Information
- Specialty Pediatric Nephrology
- Location Augusta, GA
- Active Since 04/20/2016
- Last Updated 12/06/2022
- Taxonomy Code 2080P0210X
- Entity Type Individual
- NPI Number 1043664501
Products in Payments
- TARPEYO (Drug) $121.43
- ACTHAR (Biological) $37.23
- CYSTARAN (Drug) $33.66
- LIVTENCITY (Drug) $26.64
- Cresemba (Drug) $25.67
- CARBAGLU (Drug) $23.92
- Qbrelis (Drug) $23.60
- ULTOMIRIS (Biological) $23.53
- BENLYSTA (Biological) $20.02
- JESDUVROQ (Drug) $19.44
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.